Blood clots may be removed by basic syringes or complex pumps. Syringes are easy and inexpensive, but lack speed, power, and volume. Pumps can improve power and volume, but are costly, reduce physician control, and can be difficult to operate.
Control Medical’s mechanical thrombectomy system has been safely used in over 20,000 patients to remove blood clots from the heart, brain, lungs, and legs of patients in the USA, Japan, Taiwan, Hong Kong, Australia, and Europe. Data from a multicenter study on the company’s ASPIRE MAX RX-LP system was published in February 2020 in the Journal of Invasive Cardiology. Control will launch 5 new large diameter catheters in 2020. Raising growth capital.